Free Trial

Hemostemix (HEM) Insider Trading & Ownership

Hemostemix logo
C$0.08 -0.01 (-5.88%)
(As of 11/22/2024 05:18 PM ET)

Hemostemix (CVE:HEM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.43%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$2,790.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
C$23,719.48
Get HEM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Hemostemix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HEM Insider Buying and Selling by Quarter

Hemostemix Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/18/2024Thomas SmeenkDirectorSell28,093C$0.08C$2,106.98
10/8/2024Thomas SmeenkDirectorSell332,500C$0.07C$21,612.50
8/21/2024Thomas SmeenkDirectorBuy2,000C$0.04C$80.00
6/25/2024Thomas SmeenkDirectorBuy10,000C$0.04C$400.00
12/14/2023Thomas SmeenkDirectorBuy20,000C$0.07C$1,400.00
12/5/2023Thomas SmeenkDirectorBuy13,000C$0.07C$910.00
(Data available from 1/1/2013 forward)

HEM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Hemostemix includes Thomas Smeenk. Learn more on insiders at HEM.

10.43% of Hemostemix stock is owned by insiders. Learn more on HEM's insider holdings.

The following insider purchased HEM shares in the last 24 months: Thomas Smeenk (C$8,940.00).

Insiders have purchased a total of 90,000 HEM shares in the last 24 months for a total of C$8,940.00 bought.

The following insider sold HEM shares in the last 24 months: Thomas Smeenk (C$23,719.48).

Insiders have sold a total of 360,593 Hemostemix shares in the last 24 months for a total of C$23,719.48 sold.

Hemostemix Key Executives

  • Mr. Thomas A. Smeenk B.A. (Age 62)
    BA Hons, Co-Founder, President, CEO & Director
    Compensation: $308k
  • Ms. Christina Wu CPA
    Interim Chief Financial Officer
  • Mr. Peter Pavlin
    Vice President of Operations
  • Dr. Fraser C. Henderson Sr.
    M.D., Chief Medical Officer


This page (CVE:HEM) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners